Contemporary Multidisciplinary Treatment of Borderline-Resectable and Locally Advanced Pancreatic Adenocarcinoma [0.03%]
当代局部晚期和潜在可切除胰腺导管腺癌的综合治疗
Rachel H Joung,Rebecca A Snyder
Rachel H Joung
Pancreatic ductal adenocarcinoma remains a highly lethal malignancy, with borderline resectable (BRPC) and locally advanced pancreatic cancer (LAPC) representing biologically and anatomically complex subsets requiring coordinated multidisci...
Organ Preservation for Gastroesophageal Junction and Gastric Cancers: Ready for Primetime? [0.03%]
食管胃结合部癌和胃癌的器官保存治疗：准备就绪吗？
Winta Mehtsun,Lola Van Doosselaere,Ugwuji N Maduekwe
Winta Mehtsun
Organ preservation for gastroesophageal junction (GEJ) and gastric cancers is emerging as an attainable-but still selective-therapeutic goal. The convergence of effective systemic therapy, enhanced imaging, and endoscopic sophistication has...
Erratum: Decoding Clinical Trials in Metastatic Breast Cancer: Practical Insights for Optimal Therapy Sequencing [0.03%]
metastatic乳腺癌临床试验解读：制定最佳治疗顺序的实用见解.erratum
Chiara Corti,Hope S Rugo,Sara M Tolaney
Chiara Corti
Mikolaj Filon,Bogdana Schmidt
Mikolaj Filon
Erratum: Evolution of Targeted Therapy in Breast Cancer: Where Precision Medicine Began [0.03%]
乳腺癌靶向治疗的发展：精准医学的起源 ERRATUM
Jane Lowe Meisel,Vyshak Alva Venur,Michael Gnant et al.
Jane Lowe Meisel et al.
Urvashi Mitbander Joshi,Jasmin Hundal,Jonaphine R Mata et al.
Urvashi Mitbander Joshi et al.
Erratum: Global Oncology: Tackling Disparities and Promoting Innovations in Low- and Middle-Income Countries [0.03%]
全球肿瘤学：根除贫富差距和促进低收入和中等收入国家的创新（勘误）
Regina Barragan-Carrillo,Fredrick Chite Asirwa,Rodrigo Dienstmann et al.
Regina Barragan-Carrillo et al.
Early-Onset Colorectal Cancer: From Genetic Discovery to Clinical Innovation [0.03%]
早发性结直肠癌：从基因发现到临床创新
Anita Turk,Sebastián Mondaca,Bruno Nervi et al.
Anita Turk et al.
The rising incidence of early-onset colorectal cancer (EOCRC) presents a growing challenge to traditional approaches in screening, treatment, and survivorship. EOCRC is increasingly recognized as a biologically distinct entity, driven by co...
New Drugs, New Toxicities: Side Effects of New and Emerging Breast Cancer Therapies [0.03%]
新型药物与新型毒副反应：乳腺癌新药和新兴疗法的副作用
Alexis LeVee,Alana Deutsh,Ethan S Lindgren et al.
Alexis LeVee et al.
With the rapid introduction of novel breast cancer therapies, recognizing and managing side effects is essential to maintain adherence and improve outcomes. As novel oral endocrine therapies and combination strategies including targeted age...
Melanoma 3.0T-Tech Innovations, New Targeted Therapies, and T-Cell Breakthroughs [0.03%]
黑色素瘤3.0T技术革新、新型靶向疗法及T细胞新突破
Donald P Lawrence,Susan Swetter,Meredith McKean
Donald P Lawrence
New technologies and innovations are changing the future of melanoma care. Teledermatology and skin screening mobile apps aided by artificial intelligence (AI) diagnostic support could assist in closing disparity gaps in melanoma early dete...